DLHIX Holdings — Nomura Healthcare Fund
All 106 reported holdings of Nomura Healthcare Fund (DLHIX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Ucb SA | 5.90% | $39.21M |
| Regeneron Pharmaceuticals, Inc. | 5.46% | $36.31M |
| Pfizer Inc. | 4.83% | $32.15M |
| Gilead Sciences Inc. | 4.40% | $29.27M |
| AbbVie Inc. | 4.09% | $27.19M |
| Merck & Co., Inc | 3.89% | $25.86M |
| AstraZeneca PLC | 3.86% | $25.66M |
| Chugai Pharmaceutical Co Ltd. | 3.73% | $24.82M |
| Eli Lilly & Co. | 3.60% | $23.91M |
| Roche Holding AG | 3.30% | $21.95M |
| UnitedHealth Group Inc. | 2.85% | $18.94M |
| Elevance Health Inc. | 2.77% | $18.44M |
| Amgen Inc. | 2.49% | $16.54M |
| Viatris Inc | 2.38% | $15.81M |
| Boston Scientific Corporation | 2.36% | $15.69M |
| Halozyme Therapeutics Inc | 2.14% | $14.22M |
| Sanofi SA | 1.74% | $11.59M |
| Vertex Pharmaceuticals Incorporated | 1.68% | $11.16M |
| Illumina Inc | 1.67% | $11.09M |
| Viking Therapeutics Inc. | 1.62% | $10.74M |
| Alkermes PLC | 1.54% | $10.25M |
| Alnylam Pharmaceuticals Inc. | 1.49% | $9.93M |
| Federal National Mortgage Association | 1.42% | $9.44M |
| Roivant Sciences Ltd | 1.41% | $9.37M |
| Neurocrine Biosciences Inc | 1.39% | $9.22M |
| Cogent Biosciences, Inc. | 1.33% | $8.85M |
| Arcus Biosciences, Inc. | 1.23% | $8.19M |
| Incyte Corporation. | 1.13% | $7.53M |
| Zimmer Biomet Holdings Inc | 1.09% | $7.23M |
| Tarsus Pharmaceuticals Inc | 1.05% | $7.01M |
| Federal Home Loan Mortgage Corp. | 1.01% | $6.72M |
| Quest Diagnostics Incorporated | 0.88% | $5.88M |
| Biomarin Pharmaceutical Inc. | 0.85% | $5.65M |
| CVS Health Corp | 0.81% | $5.39M |
| BlackRock Liquidity Funds | 0.81% | $5.36M |
| Goldman Sachs Trust | 0.81% | $5.36M |
| Fidelity Colchester Street Trust | 0.81% | $5.36M |
| Morgan Stanley Institutional Liquidity Funds | 0.81% | $5.36M |
| AnaptysBio Inc. | 0.78% | $5.20M |
| Biogen Inc | 0.77% | $5.13M |
| Abivax SA | 0.75% | $5.01M |
| Stryker Corporation | 0.74% | $4.93M |
| Johnson & Johnson | 0.74% | $4.89M |
| VIR Biotechnology Inc | 0.67% | $4.48M |
| GRAIL Inc | 0.66% | $4.39M |
| Rigel Pharmaceuticals Inc. | 0.65% | $4.33M |
| Uniqure N.V. | 0.63% | $4.22M |
| Syndax Pharmaceuticals Inc. | 0.63% | $4.20M |
| Madrigal Pharmaceuticals Inc | 0.55% | $3.66M |
| Theravance Biopharma Inc | 0.51% | $3.39M |
| Monte Rosa Therapeutics Inc | 0.49% | $3.29M |
| Immunovant Inc | 0.46% | $3.03M |
| Structure Therapeutics Inc | 0.42% | $2.80M |
| Perrigo Co PLC | 0.37% | $2.47M |
| Xencor Inc | 0.36% | $2.41M |
| Day One Biopharmaceuticals, Inc. | 0.35% | $2.36M |
| Compugen Ltd. | 0.33% | $2.17M |
| Acadia Pharmaceuticals Inc | 0.31% | $2.06M |
| Arvinas Inc | 0.29% | $1.91M |
| United Therapeutics Corporation | 0.27% | $1.78M |
| BioNTech SE | 0.24% | $1.60M |
| Coherus Oncology Inc. | 0.23% | $1.52M |
| MoonLake Immunotherapeutics | 0.22% | $1.49M |
| Cosmo Pharmaceuticals NV | 0.22% | $1.48M |
| Ultragenyx Pharmaceuticals Inc | 0.22% | $1.47M |
| Regenxbio Inc. | 0.19% | $1.25M |
| Nektar Therapeutics | 0.18% | $1.23M |
| Macrogenics Inc | 0.18% | $1.21M |
| Vaxcyte Inc | 0.17% | $1.16M |
| Janux Therapeutics Inc | 0.16% | $1.06M |
| Moderna Inc | 0.15% | $1.02M |
| Proqr Therapeutics N.V | 0.15% | $1.00M |
| Cytokinetics Inc | 0.15% | $988.65K |
| Olema Pharmaceuticals, Inc. | 0.11% | $745.50K |
| Cellectis SA | 0.11% | $719.19K |
| Wave Life Sciences Ltd. | 0.09% | $594.17K |
| Viridian Therapeutics Inc | 0.09% | $574.48K |
| Instil Bio, Inc. | 0.06% | $412.00K |
| Puma Biotechnology Inc | 0.06% | $391.42K |
| Atea Pharmaceuticals Inc | 0.06% | $376.60K |
| Allogene Therapeutics Inc | 0.05% | $358.14K |
| Altimmune Inc. | 0.05% | $308.00K |
| Intellia Therapeutics Inc | 0.04% | $256.40K |
| Sarepta Therapeutics Inc | 0.04% | $239.36K |
| Myriad Genetics Inc. | 0.03% | $225.00K |
| Rocket Pharmaceuticals Inc | 0.03% | $207.64K |
| Karyopharm Therapeutics Inc | 0.03% | $185.66K |
| Organon & Co | 0.03% | $176.71K |
| Amarin Corp PLC | 0.02% | $137.37K |
| Nextcure Inc | 0.02% | $131.50K |
| Xoma Royalty Corp. | 0.02% | $108.73K |
| Sangamo Therapeutics Inc | 0.01% | $98.76K |
| Phio Pharmaceuticals Corp | 0.01% | $61.00K |
| Mirati Therapeutics, Inc. | 0.01% | $42.00K |
| Landos Biopharma, Inc. | 0.01% | $36.94K |
| Lite Strategy Inc. | 0.01% | $34.80K |
| InnoCare Pharma Ltd | 0.00% | $29.59K |
| Contra Surface Oncolog | 0.00% | $26.95K |
| Voyager Therapeutics Incorporation | 0.00% | $22.00K |
| Fortress Biotech Inc | 0.00% | $18.60K |
| Akero Therapeutics Inc | 0.00% | $16.25K |
| Euroapi SA | 0.00% | $13.32K |
| Galmed Pharmaceuticals Limited | 0.00% | $822 |
| Ambit Biosciences Corp. Cvr | 0.00% | $0 |
| Sio Gene Therapies, Inc. | 0.00% | $0 |
| Mustang Bio Inc | 0.00% | $116 |
DLHIX overview: performance, fees, allocation and SEC filings